CN Stock MarketDetailed Quotes

000999 China Resources Sanjiu Medical & Pharmaceutical

Watchlist
  • 47.61
  • +4.33+10.00%
Market Closed Sep 30 15:00 CST
61.15BMarket Cap18.12P/E (TTM)

China Resources Sanjiu Medical & Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
7.30%14.11B
14.82%7.29B
36.83%24.74B
53.65%18.61B
56.48%13.15B
49.46%6.35B
16.31%18.08B
7.53%12.11B
6.82%8.4B
4.18%4.25B
Operating revenue
7.30%14.11B
14.82%7.29B
36.83%24.74B
53.65%18.61B
56.48%13.15B
49.46%6.35B
16.31%18.08B
7.53%12.11B
6.82%8.4B
4.18%4.25B
Other operating revenue
-32.65%372.96M
----
34.95%901.47M
----
51.43%553.78M
----
-7.14%667.99M
----
5.24%365.69M
----
Total operating cost
3.32%11.02B
13.81%5.49B
37.80%21.02B
57.00%15.41B
60.36%10.67B
48.74%4.82B
16.69%15.25B
6.66%9.81B
7.04%6.65B
-2.03%3.24B
Operating cost
4.28%6.55B
16.46%3.4B
39.14%11.57B
63.79%8.97B
65.75%6.28B
51.22%2.92B
30.83%8.31B
19.66%5.48B
19.71%3.79B
16.63%1.93B
Operating tax surcharges
10.37%149.98M
14.18%75.25M
32.77%274.91M
46.96%193.82M
50.55%135.89M
41.96%65.9M
1.27%207.06M
-0.21%131.88M
-3.98%90.27M
-6.70%46.42M
Operating expense
0.69%3.31B
11.26%1.56B
37.21%6.97B
48.90%4.77B
52.75%3.29B
43.32%1.4B
0.80%5.08B
-9.99%3.2B
-7.95%2.15B
-27.69%979.22M
Administration expense
4.25%706.27M
9.57%338.68M
43.92%1.52B
56.99%1.04B
55.50%677.45M
61.69%309.11M
10.81%1.06B
8.35%662.21M
6.53%435.65M
1.94%191.18M
Financial expense
-87.10%-24.67M
-223.79%-23.66M
-539.25%-24.19M
-91.99%-20.52M
59.86%-13.19M
17.82%-7.31M
114.57%5.51M
65.20%-10.69M
-7.17%-32.85M
35.46%-8.89M
-Interest expense (Financial expense)
59.47%43.12M
114.47%20.82M
280.56%80.78M
266.28%52.29M
233.48%27.04M
162.78%9.71M
49.71%21.23M
52.77%14.28M
25.55%8.11M
63.57%3.69M
-Interest Income (Financial expense)
-73.62%-68.61M
-201.37%-46.12M
-45.43%-106.86M
-44.37%-72.75M
-7.36%-39.52M
-14.05%-15.3M
-9.32%-73.48M
4.12%-50.4M
10.03%-36.81M
21.18%-13.42M
Research and development
10.59%326.46M
3.64%137.42M
20.30%714.5M
29.95%458.44M
37.30%295.21M
27.31%132.6M
6.02%593.94M
-0.65%352.79M
-8.99%215.01M
35.90%104.15M
Credit Impairment Loss
-23.97%-72.23M
-19.89%-38.23M
-1,034.45%-67.78M
-42.63%-42.68M
-117.53%-58.27M
-108.67%-31.89M
51.76%-5.97M
-86.39%-29.93M
-43.24%-26.79M
-207.57%-15.28M
Asset Impairment Loss
-40.73%-25.19M
12.92%-20.54M
-24.85%-172.64M
-125.15%-78.07M
23.32%-17.9M
-20.57%-23.59M
46.09%-138.27M
44.66%-34.67M
-63.66%-23.34M
-74.93%-19.56M
Other net revenue
233.20%61.3M
45.51%-9.51M
-70.75%35.87M
-59.14%51.59M
-71.69%18.4M
-198.39%-17.46M
18,412.22%122.63M
29.46%126.25M
-32.07%64.98M
135.72%17.74M
Fair value change income
158.55%2.08M
94.60%-321.82K
-1,209.83%-28.63M
-385.42%-6.6M
-153.74%-3.56M
---5.96M
-48.79%2.58M
-31.88%2.31M
142.89%6.62M
----
Invest income
174.96%12.46M
-30.30%2.17M
-59.13%18.24M
-56.42%10.85M
-71.37%4.53M
5.47%3.11M
31.79%44.62M
48.18%24.9M
85.96%15.82M
-47.62%2.95M
-Including: Investment income associates
-475.05%-7.18M
-235.42%-1.35M
-11.37%5.2M
1,057.82%5.23M
683.83%1.91M
384.54%995.83K
3,057.34%5.87M
-171.35%-545.76K
-62.23%244.09K
-68.13%205.52K
Asset deal income
-84.94%321.85K
-10.05%843.5K
-64.28%813.69K
-16.34%2.68M
42.57%2.14M
-4.89%937.69K
167.98%2.28M
193.66%3.21M
1.31%1.5M
822.58%985.88K
Other revenue
57.30%143.85M
16.61%46.57M
31.50%285.87M
3.10%165.41M
0.32%91.45M
-17.91%39.94M
-5.39%217.39M
3.54%160.43M
-21.34%91.16M
167.53%48.65M
Operating profit
25.95%3.15B
18.76%1.8B
27.35%3.75B
34.20%3.25B
37.68%2.5B
47.46%1.51B
19.21%2.95B
12.27%2.42B
3.91%1.82B
31.82%1.03B
Add:Non operating Income
29.16%25.75M
194.43%11.82M
44.31%51.29M
39.27%27.2M
114.68%19.94M
57.01%4.01M
64.05%35.54M
76.73%19.53M
64.07%9.29M
-27.01%2.56M
Less:Non operating expense
-40.34%14.05M
-18.56%6.56M
159.85%50.21M
99.31%27.77M
158.61%23.55M
95.84%8.06M
-61.33%19.32M
-64.87%13.93M
-26.75%9.1M
39.07%4.12M
Total profit
26.60%3.16B
19.43%1.8B
26.69%3.75B
33.86%3.25B
37.47%2.5B
47.29%1.51B
21.25%2.96B
14.04%2.43B
4.32%1.82B
31.53%1.03B
Less:Income tax cost
33.64%582.11M
24.82%349.98M
24.56%580.97M
23.38%554.54M
18.79%435.57M
59.76%280.39M
35.04%466.43M
28.57%449.47M
4.33%366.68M
33.36%175.51M
Net profit
25.11%2.58B
18.20%1.45B
27.09%3.17B
36.24%2.7B
42.20%2.06B
44.71%1.23B
18.98%2.5B
11.18%1.98B
4.32%1.45B
31.16%849.6M
Net profit from continuing operation
25.11%2.58B
18.20%1.45B
27.09%3.17B
36.24%2.7B
42.20%2.06B
44.71%1.23B
18.98%2.5B
11.18%1.98B
4.32%1.45B
31.16%849.6M
Less:Minority Profit
-2.21%178.69M
13.91%89.34M
564.91%320.55M
1,031.76%292.58M
1,076.61%182.73M
789.68%78.43M
10.85%48.21M
11.98%25.85M
21.24%15.53M
82.48%8.82M
Net profit of parent company owners
27.77%2.4B
18.49%1.36B
16.50%2.85B
23.06%2.4B
30.99%1.88B
36.90%1.15B
19.16%2.45B
11.17%1.95B
4.16%1.43B
30.77%840.79M
Earning per share
Basic earning per share
27.21%1.87
19.83%1.39
16.94%2.9
22.61%2.44
0.68%1.47
34.88%1.16
18.10%2.48
11.17%1.99
3.55%1.46
30.30%0.86
Diluted earning per share
27.21%1.87
19.83%1.39
16.94%2.9
22.61%2.44
0.68%1.47
34.88%1.16
18.10%2.48
11.17%1.99
3.55%1.46
30.30%0.86
Other composite income
-100.41%-29.84K
97.77%-96.17K
-107.40%-5.21M
-87.37%4.61M
1,703.99%7.23M
-6,656.29%-4.32M
1,273.94%70.39M
307.34%36.48M
-40.98%400.52K
-263.79%-63.88K
Other composite income of parent company owners
-99.37%43.04K
99.49%-21.16K
-99.06%664.35K
-85.23%5.39M
1,593.27%6.78M
-6,356.30%-4.12M
1,259.34%70.38M
307.34%36.48M
-40.98%400.52K
-263.79%-63.88K
Other composite income of minority owners
-116.43%-72.88K
60.86%-75K
-67,478.48%-5.87M
---781.74K
--443.47K
---191.64K
116.03%8.72K
----
----
----
Total composite income
24.67%2.58B
18.60%1.45B
23.40%3.17B
34.01%2.7B
42.66%2.07B
44.21%1.23B
22.04%2.57B
12.66%2.01B
4.30%1.45B
31.14%849.54M
Total composite income of parent company owners
27.31%2.4B
18.91%1.36B
13.27%2.85B
21.08%2.41B
31.42%1.88B
36.42%1.15B
22.27%2.52B
12.67%1.99B
4.14%1.43B
30.75%840.73M
Total composite income of minority owners
-2.49%178.62M
14.10%89.27M
552.61%314.67M
1,028.73%291.8M
1,079.46%183.18M
787.51%78.24M
11.01%48.22M
11.98%25.85M
21.24%15.53M
82.48%8.82M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 7.30%14.11B14.82%7.29B36.83%24.74B53.65%18.61B56.48%13.15B49.46%6.35B16.31%18.08B7.53%12.11B6.82%8.4B4.18%4.25B
Operating revenue 7.30%14.11B14.82%7.29B36.83%24.74B53.65%18.61B56.48%13.15B49.46%6.35B16.31%18.08B7.53%12.11B6.82%8.4B4.18%4.25B
Other operating revenue -32.65%372.96M----34.95%901.47M----51.43%553.78M-----7.14%667.99M----5.24%365.69M----
Total operating cost 3.32%11.02B13.81%5.49B37.80%21.02B57.00%15.41B60.36%10.67B48.74%4.82B16.69%15.25B6.66%9.81B7.04%6.65B-2.03%3.24B
Operating cost 4.28%6.55B16.46%3.4B39.14%11.57B63.79%8.97B65.75%6.28B51.22%2.92B30.83%8.31B19.66%5.48B19.71%3.79B16.63%1.93B
Operating tax surcharges 10.37%149.98M14.18%75.25M32.77%274.91M46.96%193.82M50.55%135.89M41.96%65.9M1.27%207.06M-0.21%131.88M-3.98%90.27M-6.70%46.42M
Operating expense 0.69%3.31B11.26%1.56B37.21%6.97B48.90%4.77B52.75%3.29B43.32%1.4B0.80%5.08B-9.99%3.2B-7.95%2.15B-27.69%979.22M
Administration expense 4.25%706.27M9.57%338.68M43.92%1.52B56.99%1.04B55.50%677.45M61.69%309.11M10.81%1.06B8.35%662.21M6.53%435.65M1.94%191.18M
Financial expense -87.10%-24.67M-223.79%-23.66M-539.25%-24.19M-91.99%-20.52M59.86%-13.19M17.82%-7.31M114.57%5.51M65.20%-10.69M-7.17%-32.85M35.46%-8.89M
-Interest expense (Financial expense) 59.47%43.12M114.47%20.82M280.56%80.78M266.28%52.29M233.48%27.04M162.78%9.71M49.71%21.23M52.77%14.28M25.55%8.11M63.57%3.69M
-Interest Income (Financial expense) -73.62%-68.61M-201.37%-46.12M-45.43%-106.86M-44.37%-72.75M-7.36%-39.52M-14.05%-15.3M-9.32%-73.48M4.12%-50.4M10.03%-36.81M21.18%-13.42M
Research and development 10.59%326.46M3.64%137.42M20.30%714.5M29.95%458.44M37.30%295.21M27.31%132.6M6.02%593.94M-0.65%352.79M-8.99%215.01M35.90%104.15M
Credit Impairment Loss -23.97%-72.23M-19.89%-38.23M-1,034.45%-67.78M-42.63%-42.68M-117.53%-58.27M-108.67%-31.89M51.76%-5.97M-86.39%-29.93M-43.24%-26.79M-207.57%-15.28M
Asset Impairment Loss -40.73%-25.19M12.92%-20.54M-24.85%-172.64M-125.15%-78.07M23.32%-17.9M-20.57%-23.59M46.09%-138.27M44.66%-34.67M-63.66%-23.34M-74.93%-19.56M
Other net revenue 233.20%61.3M45.51%-9.51M-70.75%35.87M-59.14%51.59M-71.69%18.4M-198.39%-17.46M18,412.22%122.63M29.46%126.25M-32.07%64.98M135.72%17.74M
Fair value change income 158.55%2.08M94.60%-321.82K-1,209.83%-28.63M-385.42%-6.6M-153.74%-3.56M---5.96M-48.79%2.58M-31.88%2.31M142.89%6.62M----
Invest income 174.96%12.46M-30.30%2.17M-59.13%18.24M-56.42%10.85M-71.37%4.53M5.47%3.11M31.79%44.62M48.18%24.9M85.96%15.82M-47.62%2.95M
-Including: Investment income associates -475.05%-7.18M-235.42%-1.35M-11.37%5.2M1,057.82%5.23M683.83%1.91M384.54%995.83K3,057.34%5.87M-171.35%-545.76K-62.23%244.09K-68.13%205.52K
Asset deal income -84.94%321.85K-10.05%843.5K-64.28%813.69K-16.34%2.68M42.57%2.14M-4.89%937.69K167.98%2.28M193.66%3.21M1.31%1.5M822.58%985.88K
Other revenue 57.30%143.85M16.61%46.57M31.50%285.87M3.10%165.41M0.32%91.45M-17.91%39.94M-5.39%217.39M3.54%160.43M-21.34%91.16M167.53%48.65M
Operating profit 25.95%3.15B18.76%1.8B27.35%3.75B34.20%3.25B37.68%2.5B47.46%1.51B19.21%2.95B12.27%2.42B3.91%1.82B31.82%1.03B
Add:Non operating Income 29.16%25.75M194.43%11.82M44.31%51.29M39.27%27.2M114.68%19.94M57.01%4.01M64.05%35.54M76.73%19.53M64.07%9.29M-27.01%2.56M
Less:Non operating expense -40.34%14.05M-18.56%6.56M159.85%50.21M99.31%27.77M158.61%23.55M95.84%8.06M-61.33%19.32M-64.87%13.93M-26.75%9.1M39.07%4.12M
Total profit 26.60%3.16B19.43%1.8B26.69%3.75B33.86%3.25B37.47%2.5B47.29%1.51B21.25%2.96B14.04%2.43B4.32%1.82B31.53%1.03B
Less:Income tax cost 33.64%582.11M24.82%349.98M24.56%580.97M23.38%554.54M18.79%435.57M59.76%280.39M35.04%466.43M28.57%449.47M4.33%366.68M33.36%175.51M
Net profit 25.11%2.58B18.20%1.45B27.09%3.17B36.24%2.7B42.20%2.06B44.71%1.23B18.98%2.5B11.18%1.98B4.32%1.45B31.16%849.6M
Net profit from continuing operation 25.11%2.58B18.20%1.45B27.09%3.17B36.24%2.7B42.20%2.06B44.71%1.23B18.98%2.5B11.18%1.98B4.32%1.45B31.16%849.6M
Less:Minority Profit -2.21%178.69M13.91%89.34M564.91%320.55M1,031.76%292.58M1,076.61%182.73M789.68%78.43M10.85%48.21M11.98%25.85M21.24%15.53M82.48%8.82M
Net profit of parent company owners 27.77%2.4B18.49%1.36B16.50%2.85B23.06%2.4B30.99%1.88B36.90%1.15B19.16%2.45B11.17%1.95B4.16%1.43B30.77%840.79M
Earning per share
Basic earning per share 27.21%1.8719.83%1.3916.94%2.922.61%2.440.68%1.4734.88%1.1618.10%2.4811.17%1.993.55%1.4630.30%0.86
Diluted earning per share 27.21%1.8719.83%1.3916.94%2.922.61%2.440.68%1.4734.88%1.1618.10%2.4811.17%1.993.55%1.4630.30%0.86
Other composite income -100.41%-29.84K97.77%-96.17K-107.40%-5.21M-87.37%4.61M1,703.99%7.23M-6,656.29%-4.32M1,273.94%70.39M307.34%36.48M-40.98%400.52K-263.79%-63.88K
Other composite income of parent company owners -99.37%43.04K99.49%-21.16K-99.06%664.35K-85.23%5.39M1,593.27%6.78M-6,356.30%-4.12M1,259.34%70.38M307.34%36.48M-40.98%400.52K-263.79%-63.88K
Other composite income of minority owners -116.43%-72.88K60.86%-75K-67,478.48%-5.87M---781.74K--443.47K---191.64K116.03%8.72K------------
Total composite income 24.67%2.58B18.60%1.45B23.40%3.17B34.01%2.7B42.66%2.07B44.21%1.23B22.04%2.57B12.66%2.01B4.30%1.45B31.14%849.54M
Total composite income of parent company owners 27.31%2.4B18.91%1.36B13.27%2.85B21.08%2.41B31.42%1.88B36.42%1.15B22.27%2.52B12.67%1.99B4.14%1.43B30.75%840.73M
Total composite income of minority owners -2.49%178.62M14.10%89.27M552.61%314.67M1,028.73%291.8M1,079.46%183.18M787.51%78.24M11.01%48.22M11.98%25.85M21.24%15.53M82.48%8.82M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----KPMG Huazhen Certified Public Accountants (Special General Partnership)------Ernst & Young (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data